Financhill
Sell
37

CHTR Quote, Financials, Valuation and Earnings

Last price:
$396.05
Seasonality move :
9.28%
Day range:
$388.06 - $397.34
52-week range:
$272.49 - $437.06
Dividend yield:
0%
P/E ratio:
11.06x
P/S ratio:
1.04x
P/B ratio:
3.42x
Volume:
1.8M
Avg. volume:
1.5M
1-year change:
43.52%
Market cap:
$55.6B
Revenue:
$55.1B
EPS (TTM):
$35.83
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $48.1B $51.7B $54B $54.6B $55.1B
Revenue Growth (YoY) 5.1% 7.45% 4.53% 1.08% 0.88%
 
Cost of Revenues $26.9B $28.2B $24.5B $24.6B $24.3B
Gross Profit $21.2B $23.5B $29.5B $30B $30.8B
Gross Profit Margin 44.07% 45.39% 54.63% 54.88% 55.87%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $3B $3.3B $4.1B $4.3B $4.4B
Other Inc / (Exp) -$313M -$430M -$225M -$464M -$514M
Operating Expenses $12.7B $12.6B $17.3B $17.5B $17.5B
Operating Income $8.5B $10.9B $12.2B $12.5B $13.2B
 
Net Interest Expenses $3.8B $4B $4.6B $5.2B $5.2B
EBT. Incl. Unusual Items $4.3B $6.4B $7.5B $6.9B $7.5B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $626M $1.1B $1.6B $1.6B $1.6B
Net Income to Company $3.7B $5.3B $5.8B $5.3B $5.9B
 
Minority Interest in Earnings -$454M -$666M -$794M -$704M -$770M
Net Income to Common Excl Extra Items $3.2B $4.7B $5.1B $4.6B $5.1B
 
Basic EPS (Cont. Ops) $15.85 $25.34 $31.30 $30.54 $35.53
Diluted EPS (Cont. Ops) $15.40 $24.47 $30.74 $29.99 $34.97
Weighted Average Basic Share $203.3M $183.7M $161.5M $149.2M $143.1M
Weighted Average Diluted Share $209.3M $193M $164.4M $152M $145.4M
 
EBITDA $17.9B $19.8B $20.9B $20.7B $21.4B
EBIT $8.2B $10.4B $12B $12B $12.7B
 
Revenue (Reported) $48.1B $51.7B $54B $54.6B $55.1B
Operating Income (Reported) $8.5B $10.9B $12.2B $12.5B $13.2B
Operating Income (Adjusted) $8.2B $10.4B $12B $12B $12.7B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $12.5B $13.2B $13.7B $13.7B $13.7B
Revenue Growth (YoY) 6.68% 5.42% 3.43% 0.19% 0.41%
 
Cost of Revenues $7B $8.1B $7.6B $7.3B $7B
Gross Profit $5.6B $5.1B $6.1B $6.4B $6.7B
Gross Profit Margin 44.42% 38.38% 44.59% 46.63% 48.87%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $751M -- $946M $1.1B $1.2B
Other Inc / (Exp) -$250M $22M -$114M -$51M -$265M
Operating Expenses $3.2B $2.3B $3.2B $3.3B $3.4B
Operating Income $2.4B $2.8B $2.9B $3.1B $3.4B
 
Net Interest Expenses $983M $1.1B $1.3B $1.3B $1.2B
EBT. Incl. Unusual Items $1.1B $1.7B $1.6B $1.7B $1.9B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $216M $345M $374M $446M $445M
Net Income to Company $921M $1.4B $1.2B $1.3B $1.4B
 
Minority Interest in Earnings -$114M -$186M -$162M -$174M -$192M
Net Income to Common Excl Extra Items $807M $1.2B $1B $1.1B $1.2B
 
Basic EPS (Cont. Ops) $4.22 $7.05 $6.74 $7.66 $8.59
Diluted EPS (Cont. Ops) $4.11 $6.90 $6.65 $7.55 $8.42
Weighted Average Basic Share $191.4M $170.7M $151.4M $144.5M $141.6M
Weighted Average Diluted Share $205.9M $174.5M $153.5M $146.6M $144.6M
 
EBITDA $4.6B $5.1B $5B $5.2B $5.3B
EBIT $2.1B $2.8B $2.8B $3B $3.1B
 
Revenue (Reported) $12.5B $13.2B $13.7B $13.7B $13.7B
Operating Income (Reported) $2.4B $2.8B $2.9B $3.1B $3.4B
Operating Income (Adjusted) $2.1B $2.8B $2.8B $3B $3.1B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $48.9B $52.4B $54.5B $54.6B $55.1B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $27.2B $29.4B $25.7B $23.4B $22.9B
Gross Profit $21.7B $23B $28.8B $31.2B $32.2B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $3B $3.4B $4.1B -- --
Other Inc / (Exp) -$230M -$158M -$361M -$401M -$728M
Operating Expenses $12.7B $11.7B $16.4B $18.5B $18.7B
Operating Income $9B $11.3B $12.4B $12.7B $13.5B
 
Net Interest Expenses $3.9B $4.1B $4.8B $5.2B $5.2B
EBT. Incl. Unusual Items $4.9B $7B $7.3B $7B $7.6B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $813M $1.2B $1.6B $1.7B $1.6B
Net Income to Company $4.1B $5.8B $5.6B $5.4B $6B
 
Minority Interest in Earnings -$497M -$738M -$770M -$716M -$788M
Net Income to Common Excl Extra Items $3.6B $5.1B $4.9B $4.6B $5.2B
 
Basic EPS (Cont. Ops) $18.28 $28.39 $31.00 $31.46 $36.48
Diluted EPS (Cont. Ops) $17.69 $27.62 $30.52 $30.92 $35.83
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $18.4B $20.3B $20.9B $20.9B $21.4B
EBIT $8.8B $11.1B $12B $12.3B $12.8B
 
Revenue (Reported) $48.9B $52.4B $54.5B $54.6B $55.1B
Operating Income (Reported) $9B $11.3B $12.4B $12.7B $13.5B
Operating Income (Adjusted) $8.8B $11.1B $12B $12.3B $12.8B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $12.5B $13.2B $13.7B $13.7B $13.7B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $7B $8.1B $7.6B $7.3B $7B
Gross Profit $5.6B $5.1B $6.1B $6.4B $6.7B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $751M -- $946M $1.1B $1.2B
Other Inc / (Exp) -$250M $22M -$114M -$51M -$265M
Operating Expenses $3.2B $2.3B $3.2B $3.3B $3.4B
Operating Income $2.4B $2.8B $2.9B $3.1B $3.4B
 
Net Interest Expenses $983M $1.1B $1.3B $1.3B $1.2B
EBT. Incl. Unusual Items $1.1B $1.7B $1.6B $1.7B $1.9B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $216M $345M $374M $446M $445M
Net Income to Company $921M $1.4B $1.2B $1.3B $1.4B
 
Minority Interest in Earnings -$114M -$186M -$162M -$174M -$192M
Net Income to Common Excl Extra Items $807M $1.2B $1B $1.1B $1.2B
 
Basic EPS (Cont. Ops) $4.22 $7.05 $6.74 $7.66 $8.59
Diluted EPS (Cont. Ops) $4.11 $6.90 $6.65 $7.55 $8.42
Weighted Average Basic Share $191.4M $170.7M $151.4M $144.5M $141.6M
Weighted Average Diluted Share $205.9M $174.5M $153.5M $146.6M $144.6M
 
EBITDA $4.6B $5.1B $5B $5.2B $5.3B
EBIT $2.1B $2.8B $2.8B $3B $3.1B
 
Revenue (Reported) $12.5B $13.2B $13.7B $13.7B $13.7B
Operating Income (Reported) $2.4B $2.8B $2.9B $3.1B $3.4B
Operating Income (Adjusted) $2.1B $2.8B $2.8B $3B $3.1B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $1B $601M $645M $709M $459M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $2.5B $2.6B $2.9B $3B $3.1B
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets $369M $386M $451M $458M $677M
Total Current Assets $3.9B $3.6B $4B $4.1B $4.2B
 
Property Plant And Equipment $34.4B $34.3B $36B $39.5B $42.9B
Long-Term Investments -- -- -- -- --
Goodwill $29.6B $29.6B $29.6B $29.7B $29.7B
Other Intangibles $72.9B $71.4B $70.1B $69.1B $68.4B
Other Long-Term Assets $3.4B $3.6B $4.8B $4.7B $4.8B
Total Assets $144.2B $142.5B $144.5B $147.2B $150B
 
Accounts Payable $763M $724M $952M $931M $880M
Accrued Expenses $6.9B $6.2B $6.2B $6.3B $7.1B
Current Portion Of Long-Term Debt $1B $3B $1.5B $2.4B $2.6B
Current Portion Of Capital Lease Obligations $235M $269M -- -- --
Other Current Liabilities -- $1.2B $2.2B $2.4B $1.9B
Total Current Liabilities $9.9B $12.5B $12.1B $13.2B $13.5B
 
Long-Term Debt $81.7B $88.6B $96.1B $95.8B $93.2B
Capital Leases -- -- -- -- --
Total Liabilities $113.9B $124.3B $132B $132.5B $130.3B
 
Common Stock -- -- -- -- --
Other Common Equity Adj -- -- -- -- --
Common Equity $23.8B $14.1B $9.1B $11.1B $15.6B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $6.5B $4.1B $3.4B $3.6B $4.1B
Total Equity $30.3B $18.2B $12.5B $14.7B $19.7B
 
Total Liabilities and Equity $144.2B $142.5B $144.5B $147.2B $150B
Cash and Short Terms $1B $601M $645M $709M $459M
Total Debt $82.8B $91.6B $97.6B $98.2B $95.8B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $772M $2.4B $534M $661M $796M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $2.4B $2.5B $2.9B $3B $3.3B
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets $496M $555M $682M $731M $861M
Total Current Assets $3.7B $5.5B $4.1B $4.4B $5B
 
Property Plant And Equipment $34.2B $34.2B $36.6B $40.3B $43.4B
Long-Term Investments -- -- -- -- --
Goodwill $29.6B $29.6B $29.6B $29.7B $29.7B
Other Intangibles $73.4B $71B $69.8B $68.9B $68.3B
Other Long-Term Assets $2.7B $3.7B $4.8B $4.7B $4.7B
Total Assets $143.4B $143.9B $144.9B $148B $151B
 
Accounts Payable $724M $706M $746M $850M $929M
Accrued Expenses $5.8B $6.1B $6.2B $6B $6.8B
Current Portion Of Long-Term Debt $1B $4.5B $2B -- --
Current Portion Of Capital Lease Obligations $245M $275M $292M -- --
Other Current Liabilities $1.1B $964M $1.5B $2.6B $2.1B
Total Current Liabilities $9.9B $13.9B $12.2B $10.9B $13.7B
 
Long-Term Debt $83.9B $90.7B $96B $98B $93.2B
Capital Leases -- -- -- -- --
Total Liabilities $116.3B $128B $132B $132.4B $130.4B
 
Common Stock -- -- -- -- --
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $6.2B $3.9B $3.5B $3.7B $4.3B
Total Equity $27.2B $15.9B $12.9B $15.6B $20.5B
 
Total Liabilities and Equity $143.4B $143.9B $144.9B $148B $151B
Cash and Short Terms $772M $2.4B $534M $661M $796M
Total Debt $84.9B $95.2B $98B $98B $95.6B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $3.7B $5.3B $5.8B $5.3B $5.9B
Depreciation & Amoritzation $9.7B $9.3B $8.9B $8.7B $8.7B
Stock-Based Compensation $351M $430M $470M $692M $651M
Change in Accounts Receivable -$67M -$35M -$342M -$44M -$129M
Change in Inventories -- -- -- -- --
Cash From Operations $14.6B $16.2B $14.9B $14.4B $14.4B
 
Capital Expenditures $8B $7.6B $9.4B $11.1B $11.3B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$8.2B -$7.8B -$9.1B -$11.1B -$10.7B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $15.8B $21B $25.6B $22.1B $27B
Long-Term Debt Repaid -$12.1B -$12.1B -$19.3B -$21.9B -$29.7B
Repurchase of Common Stock -$11.2B -$15.4B -$10.3B -$3.2B -$1.2B
Other Financing Activities -$1.6B -$2.3B -$1.8B -$173M -$105M
Cash From Financing -$9B -$8.9B -$5.8B -$3.2B -$4B
 
Beginning Cash (CF) $3.5B $1B $601M $645M $709M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$2.5B -$400M $44M $64M -$203M
Ending Cash (CF) $1B $601M $645M $709M $506M
 
Levered Free Cash Flow $6.6B $8.7B $5.5B $3.3B $3.2B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $921M $1.4B $1.2B $1.3B $1.4B
Depreciation & Amoritzation $2.4B $2.3B $2.2B $2.2B $2.2B
Stock-Based Compensation $134M $147M $208M $214M $222M
Change in Accounts Receivable $144M $49M $70M -$39M -$48M
Change in Inventories -- -- -- -- --
Cash From Operations $3.8B $3.6B $3.3B $3.2B $4.2B
 
Capital Expenditures $1.9B $1.8B $2.7B $2.9B $2.7B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$2B -$1.8B -$2.7B -$2.9B -$2.8B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $5.3B $6.7B $7.1B $5.9B $1.5B
Long-Term Debt Repaid -$3.2B -$3B -$6.7B -$5.7B -$1.6B
Repurchase of Common Stock -$3.7B -$3.3B -$912M -$516M -$802M
Other Financing Activities -$506M -$457M -$149M -$44M -$192M
Cash From Financing -$2B -$30M -$695M -$353M -$1.1B
 
Beginning Cash (CF) $1B $601M $645M $709M $506M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$229M $1.8B -$111M -$48M $360M
Ending Cash (CF) $772M $2.4B $534M $661M $866M
 
Levered Free Cash Flow $1.9B $1.8B $664M $358M $1.6B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $4.1B $5.8B $5.6B $5.4B $6B
Depreciation & Amoritzation $9.6B $9.2B $8.8B $8.7B $8.7B
Stock-Based Compensation $395M $443M $531M $698M $659M
Change in Accounts Receivable -$22M -$130M -$321M -$153M -$138M
Change in Inventories -- -- -- -- --
Cash From Operations $15.1B $16.1B $14.6B $14.3B $15.5B
 
Capital Expenditures $8B $7.5B $10.2B $11.3B $11.1B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$8.3B -$7.6B -$10.1B -$11.3B -$10.6B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $16.7B $22.4B $26B $20.9B $22.6B
Long-Term Debt Repaid -$11.7B -$11.9B -$23.1B -$20.9B -$25.6B
Repurchase of Common Stock -$12.5B -$15.1B -$7.9B -$2.8B -$1.5B
Other Financing Activities -$1.6B -$2.3B -$1.5B -$68M -$253M
Cash From Financing -$9B -$6.9B -$6.4B -$2.9B -$4.7B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$2.2B $1.7B -$1.9B $127M $205M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $7.1B $8.6B $4.4B $3B $4.4B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $921M $1.4B $1.2B $1.3B $1.4B
Depreciation & Amoritzation $2.4B $2.3B $2.2B $2.2B $2.2B
Stock-Based Compensation $134M $147M $208M $214M $222M
Change in Accounts Receivable $144M $49M $70M -$39M -$48M
Change in Inventories -- -- -- -- --
Cash From Operations $3.8B $3.6B $3.3B $3.2B $4.2B
 
Capital Expenditures $1.9B $1.8B $2.7B $2.9B $2.7B
Cash Acquisitions -- -- -- -- --
Cash From Investing -$2B -$1.8B -$2.7B -$2.9B -$2.8B
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $5.3B $6.7B $7.1B $5.9B $1.5B
Long-Term Debt Repaid -$3.2B -$3B -$6.7B -$5.7B -$1.6B
Repurchase of Common Stock -$3.7B -$3.3B -$912M -$516M -$802M
Other Financing Activities -$506M -$457M -$149M -$44M -$192M
Cash From Financing -$2B -$30M -$695M -$353M -$1.1B
 
Beginning Cash (CF) $1B $601M $645M $709M $506M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$229M $1.8B -$111M -$48M $360M
Ending Cash (CF) $772M $2.4B $534M $661M $866M
 
Levered Free Cash Flow $1.9B $1.8B $664M $358M $1.6B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Best AI Index Fund to Buy
Best AI Index Fund to Buy

Over the last two years, companies with a focus on…

Where Will Salesforce Stock Be in 5 Years?
Where Will Salesforce Stock Be in 5 Years?

Salesforce (NYSE: CRM) just turned in a quarter that, on…

2 Ultra Safe Dividend Stocks to Buy Now
2 Ultra Safe Dividend Stocks to Buy Now

Historically, blue-chip dividend stocks have been good choices for periods…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for May 31

Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.

Buy
55
RGC alert for May 31

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Sell
42
AMBA alert for May 31

Ambarella [AMBA] is down 15.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock